~~<i id='917B3C6CCD'><strike id='917B3C6CCD'><tt id='917B3C6CCD'><pre id='917B3C6CCD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：explore 2025-09-02 17:36:01 - browse：41498

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

explore

leisure time

entertainment

hotspot

explore

AdobeAspartoftheBidenadministration’sbroadereffortstolowerhealthcarecosts,theWhiteHouseannouncednewg

WSS

Colonoscopy prep: Liquid

Virtual Event: March of the Biosimilars

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Methadone treatment changes are coming. Do they go far enough?

The U.S. needs a new definition of substance use “recovery”

Creating egg and sperm cells from stem cells raises ethical issues

leisure time

hotspot

explore

Hollywood unions extend contract negotiations for actors

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Hepatitis C has a cure — but many Americans still lack access to it

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

After affirmative action ruling, medical educators look to 'holistic review'

Intermittent fasting comes with a heart risk? Not so fast

At least 13 dead in Texas as scorching temps continue

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Heart attack and stroke risk calculators need revising

Methadone treatment changes are coming. Do they go far enough?

leisure time

Positive childhood experiences can help future health

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Medicare wants to send $9 billion to 340B hospitals

Judge agrees to delay next hearing in Trump classified documents case

Eisai exec who led development of Alzheimer’s drug to retire

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

leisure time

entertainment

hotspot

explore